PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China
· Delayed Price · Currency is CNY 40.01
-0.69 (-1.70%)
Apr 29, 2026, 3:04 PM CST
SHE:300725 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 9,321 | 8,983 | 6,681 | 7,841 | 16,073 | 28,391 | Upgrade
|
| Market Cap Growth | 27.77% | 34.47% | -14.80% | -51.22% | -43.39% | 41.66% | Upgrade
|
| Enterprise Value | 8,370 | 8,183 | 7,577 | 8,455 | 16,316 | 27,695 | Upgrade
|
| Last Close Price | 40.01 | 38.56 | 33.33 | 38.55 | 78.87 | 139.14 | Upgrade
|
| PE Ratio | 44.17 | 48.89 | 30.43 | 39.73 | 51.15 | 58.35 | Upgrade
|
| Forward PE | 40.01 | 37.71 | 26.11 | 27.44 | 37.00 | 65.42 | Upgrade
|
| PS Ratio | 4.60 | 4.55 | 3.96 | 4.55 | 10.08 | 23.63 | Upgrade
|
| PB Ratio | 1.70 | 1.43 | 2.24 | 2.77 | 6.05 | 10.81 | Upgrade
|
| P/TBV Ratio | 1.85 | 1.54 | 2.65 | 3.31 | 7.34 | 14.49 | Upgrade
|
| P/FCF Ratio | 34.95 | 17.04 | 36.17 | - | - | - | Upgrade
|
| P/OCF Ratio | 19.78 | 13.46 | 22.06 | 31.77 | 65.18 | 119.28 | Upgrade
|
| EV/Sales Ratio | 4.13 | 4.14 | 4.49 | 4.90 | 10.23 | 23.05 | Upgrade
|
| EV/EBITDA Ratio | 20.51 | 20.90 | 21.32 | 22.59 | 44.53 | 85.84 | Upgrade
|
| EV/EBIT Ratio | 31.50 | 32.14 | 33.43 | 32.53 | 58.23 | 102.79 | Upgrade
|
| EV/FCF Ratio | 31.39 | 15.52 | 41.03 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.47 | 0.62 | 0.59 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 0.28 | 0.29 | 3.95 | 4.65 | 4.27 | 1.17 | Upgrade
|
| Debt / FCF Ratio | 0.42 | 0.21 | 7.66 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.17 | -0.18 | 0.01 | 0.05 | -0.02 | -0.28 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.35 | -2.95 | 0.11 | 0.40 | -0.12 | -2.24 | Upgrade
|
| Net Debt / FCF Ratio | -3.56 | -2.19 | 0.22 | -2.14 | 0.14 | 2.70 | Upgrade
|
| Asset Turnover | 0.36 | 0.32 | 0.34 | 0.35 | 0.38 | 0.41 | Upgrade
|
| Inventory Turnover | 1.94 | 1.83 | 1.41 | 1.45 | 1.56 | 1.67 | Upgrade
|
| Quick Ratio | 2.40 | 2.67 | 2.48 | 1.97 | 2.64 | 1.66 | Upgrade
|
| Current Ratio | 4.23 | 4.30 | 3.63 | 2.67 | 3.60 | 2.29 | Upgrade
|
| Return on Equity (ROE) | 4.62% | 3.96% | 7.54% | 7.19% | 12.33% | 22.28% | Upgrade
|
| Return on Assets (ROA) | 2.94% | 2.59% | 2.82% | 3.26% | 4.18% | 5.68% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.85% | 5.51% | 6.65% | 8.29% | 12.41% | 21.04% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.60% | 3.80% | 5.40% | 6.40% | 6.80% | 9.90% | Upgrade
|
| Earnings Yield | 2.11% | 2.04% | 3.29% | 2.52% | 1.96% | 1.71% | Upgrade
|
| FCF Yield | 2.86% | 5.87% | 2.77% | -0.88% | -1.94% | -0.94% | Upgrade
|
| Dividend Yield | 0.69% | - | 0.84% | 0.80% | 0.13% | 0.07% | Upgrade
|
| Payout Ratio | 33.26% | 35.78% | 35.52% | 21.13% | 10.71% | 4.60% | Upgrade
|
| Buyback Yield / Dilution | -8.74% | -4.61% | 0.90% | -0.62% | -0.37% | -6.09% | Upgrade
|
| Total Shareholder Return | -8.06% | -4.61% | 1.74% | 0.18% | -0.24% | -6.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.